JNJ - JOHNSON & JOHNSON
162.3
-0.610 -0.376%
Share volume: 12,546,930
Last Updated: Fri 21 Feb 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.42%
PREVIOUS CLOSE
CHG
CHG%
$162.91
2.62
0.02%
View ratios
| Fiscal Date | 2023-12-31 | 2023-12-31 | 2024-03-31 | 2024-03-31 | 2024-06-30 | 2024-06-30 | 2024-09-29 | 2024-12-29 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 2025-02-13 | 2024-02-16 | 2024-05-01 | 2024-05-01 | 2024-07-25 | 2024-07-25 | 2024-10-23 | 2025-02-13 | |
| Assets | |||||||||
| Total Assets | 167.558 B | 167.558 B | 171.966 B | 171.966 B | 181.088 B | 181.088 B | 178.287 B | 180.104 B | |
| Current Assets | 53.495 B | 53.495 B | 57.002 B | 57.002 B | 57.817 B | 57.817 B | 53.249 B | 55.893 B | |
| Inventories | 11.181 B | 11.181 B | 11.383 B | 11.383 B | 12.169 B | 12.169 B | 12.603 B | 12.444 B | |
| Other Current Assets | 0.000 | 4.514 B | 0.000 | 4.455 B | 0.000 | 4.379 B | 0.000 | 0.000 | |
| Short Term Investments | 1.068 B | 4.514 B | 745.000 M | 4.455 B | 597.000 M | 4.379 B | 317.000 M | 417.000 M | |
| Total Receivables | 0.000 | 14.873 B | 0.000 | 14.946 B | 0.000 | 15.794 B | 0.000 | 0.000 | |
| Current Cash | 21.859 B | 22.927 B | 25.473 B | 26.218 B | 24.878 B | 25.475 B | 19.980 B | 24.105 B | |
| Total Non-current Assets | 0.000 | 114.063 B | 0.000 | 114.964 B | 0.000 | 123.271 B | 0.000 | 0.000 | |
| Property Plant Equipment | 19.898 B | 19.898 B | 19.632 B | 19.632 B | 19.748 B | 19.748 B | 20.479 B | 20.518 B | |
| Other Assets | 94.165 B | 9.680 B | 95.332 B | 14.125 B | 103.523 B | 10.544 B | 104.559 B | 103.693 B | |
| Intangible Assets | 0.000 | 34.175 B | 0.000 | 34.286 B | 0.000 | 39.725 B | 0.000 | 0.000 | |
| Goodwill | 0.000 | 36.558 B | 0.000 | 36.616 B | 0.000 | 44.250 B | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 167.558 B | 167.558 B | 171.966 B | 171.966 B | 181.088 B | 181.088 B | 178.287 B | 180.104 B | |
| Total liabilities | 98.784 B | 98.784 B | 101.946 B | 101.946 B | 109.550 B | 109.550 B | 108.129 B | 108.614 B | |
| Total current liabilities | 46.282 B | 46.282 B | 48.725 B | 48.725 B | 53.933 B | 53.933 B | 51.759 B | 50.321 B | |
| Accounts Payable | 9.632 B | 9.632 B | 8.174 B | 8.174 B | 8.848 B | 8.848 B | 8.954 B | 10.311 B | |
| Other liabilities | 13.398 B | 23.428 B | 15.067 B | 24.967 B | 14.086 B | 21.346 B | 14.923 B | 17.549 B | |
| Current long term debt | 0.000 | 3.451 B | 0.000 | 8.550 B | 0.000 | 9.855 B | 0.000 | 0.000 | |
| Long term debt | 25.881 B | 25.881 B | 25.082 B | 25.082 B | 31.636 B | 31.636 B | 31.289 B | 30.651 B | |
| Other liabilities | 13.398 B | 23.428 B | 15.067 B | 24.967 B | 14.086 B | 21.346 B | 14.923 B | 17.549 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 68.774 B | 68.774 B | 70.020 B | 70.020 B | 71.538 B | 71.538 B | 70.158 B | 71.490 B | |
| Common stock | 3.120 B | 2.407 B | 3.120 B | 2.408 B | 3.120 B | 2.407 B | 3.120 B | 3.120 B | |
| Retained earnings | 153.843 B | 153.843 B | 153.378 B | 153.378 B | 155.360 B | 155.360 B | 155.179 B | 155.791 B |